Management of sudden cardiac death in the young patients
Authors:
V. Illíková 1; M. Bjeloševič 1; P. Olejník 1; R. Hatala 2; M. Chalúpka 1
Authors place of work:
Detské kardiocentrum NÚSCH a. s a Lekárska fakulta Univerzity Komenského, Bratislava
1; NÚSCH a. s. a Lekárska fakulta Slovenskej zdravotníckej univerzity, Bratislava
2
Published in the journal:
Čes-slov Pediat 2018; 73 (5): 296-303.
Category:
Summary
Sudden cardiac death in the young is rare but very tragic event with a deep impact on family, medical community and lay public. The aim of the article is to provide for the professional pediatric community state-of-art knowledge about the management of pediatric patients with risk of arrhythmic sudden cardiac death. General principles of primary and secondary prevention are summarized together with specific therapeutic approaches in patients with specific arrhythmogenic entities such as structural heart diseases or primary arrhythmic syndromes.
Key words:
sudden cardiac dech, arrhythmias, young, cardiopulmonary resuscitation, prevention, management
Zdroje
1. Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Philadelphia PA: Elsevier Saunders, 2015: 1–551. ISBN: 9780808924500.
2. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Zipes DP, Libby P, Bonow RO. Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine. 8th ed. Elsevier Saunders, 2007: 933–974.
3. Fishman GI, Chugh SS, Dimarco JP, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation 2010 Nov 30; 122 (22): 2335–2348. doi: 10.1161/circulationaha.110.976092.
4. Graham R, Eisenberg M, Atkins D, et al. Strategies to improve cardiac arrest survival: a time to act. Institute of Medicine, Committee on the treatment of cardiac arrest: Current status and future directions, Board on health sciences policy. Washington (DC):National Academies Press, 2015 Sept. ISBN-13:978-0-309-37199-5.
5. Berger S, Campbell R. Sudden cardiac death in children and adolescence: introduction and overview. PACE 2009 July; 32: S2–S5. doi:10.1111/j.1540-8159.2009.02378.
6. Wren C. Sudden death in children and adolescents. Heart 2002; 88: 426–431.
7. Brugada J, Blom N, Sarquella-Brugada G, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace 2013 Sep; 15 (9): 1337–1338. doi: 10.1093/europace/eut082.
8. Gajewski KK, Saul PJ. Sudden cardiac death in children and adolescents (excluding Sudden Infant Death Syndrome). Ann Pediatr Card 2010, 3 (2):107–112. doi:10.4103/0974-2069.74035.
9. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med 1996; 334: 1039–1044. doi:10.1056/nejm199604183341607.
10. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the cardia study. Coronary artery risk development in (young) adults. Circulation 1995; 92: 785–789.
11. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long QT syndrome. Circulation 2009; 120: 761–767.
12. Lynge THE, Jeppesen AG, Winkel BG, et al. Nationwide study of sudden cardiac death in people with congenital heart defects aged 0 to 35 years. Circ. Arrhythm Electrophysiol 2018; 11: e005757. doi: 10.1161/ circep. 117. 005757.
13. Ackerman MJ, Atkins DL, Triedman JK. Sudden cardiac death in the young. Cirulation 2016 March 8; 133 (10) :1006–1026. doi:10.1161/circulationaha. 115.020254.
14. Campbell R, Berger S, Ackerman MJ. Pediatric sudden cardiac arrest. Pediatrics 2012;129;e1094; Section on cardiology and cardiac surgery. doi: 10.1542/peds.2012-0144.
15. Priori SG, Blomstrom-Lundqvist C, Mazantti A. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015 Nov 1; 36 (41): 2793–2867. doi:10.1093/eurheartj/ehv316.
16. Wisten A, Messner T. Symptoms preceding sudden cardiac death in the young are common but often misinterpreted. Scand Cardiovasc J 2005; 39 (3):143–149.
17. Cohen M. PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern. Heart Rhythm 2012; 9 (6): 1006–1024. doi:10.1016/j.hrthm.2012.03.050.
18. Kubuš P, Janoušek J. Sudden cardiac death in the young – epidemiology and prevention. Cor Vasa 2012; 54: e223–e226.
19. Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 2007; 49 (2): 240–246.
20. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 746–837.
21. Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51: e1–62.
22. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 accf/aha/hrs focused update incorporated into the accf/aha/hrs 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the american college of cardiology foundation/american heart association task force on practice guidelines and the heart rhythm society. Circulation 2013; 127: e283–352. PubMed:2325546.
23. Hatala R, Hlivák P. Comment on 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Cardiology Lett 2016; 25 (3): 157–162.
24. Cummins RO, Ornato JP, Thies WH, Pepe PE. Improving survival from sudden cardiac arrest: the „chain of survival“ concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association. Circulation 1991; 83 (5): 1832–1847.
25. Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; (35): 2733–2779. doi:10.1093/eurheartj/ehu284.
26. Marban E. Cardiac channelopathies. Nature 2002, Jan 10; 415 (6868): 213–218.
27. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for lifethreatening arrhythmias. Circulation 2001; 103: 89–95.
28. Obeyesekere M. Risk of sudden death in Wolff-Parkinson-White syndrome: How high is the risk? Circulation 2012; 125 (5): 659–660.
29. Gebauer R, Janoušek J. Supraventrikulárne tachykardie. In: Janoušek J, a kol. EKG a dysrytmie v dětském věku. 3. vyd. Praha: Grada Publishing, a.s., 2014: 117–148. ISBN 978-80-247-5006-4.
30. Etheridge SP, Escudero CA, Blaufox AD, et al. Life threatening event risk in patients with Wolf-Parkinson-White syndrome. A multicenter international study. J Am Coll Cardiol EP 2018; 4: 433–444. doi:10.1016/j.jacep.2017.10.009.
31. Kubuš P, Vít P, Gebauer RA, et al. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with Wolf-Parkinson-White electrocardiographic pattern. Circ Arrhythm Electrophysiol 2014; 7: 218–223. doi: 10.1161/circep.113.000930.
32. Pappone C, Santinelli V. Asymptomatic Wolff-Parkinson-White syndrome should be ablated. Electrophysiol Clin 2012; 4: 281–2855. doi:10.1016/ j.ccep. 2012.06.006.
Štítky
Neonatology Paediatrics General practitioner for children and adolescentsČlánok vyšiel v časopise
Czech-Slovak Pediatrics
2018 Číslo 5
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Early onset anorexia nervosa, diagnostics and treatment
- The incidence of congenital heart defects – the impact of prenatal diagnosis
- Prenatal detection of congenital heart defects and its consequences
- Local reactions after snakebite – clinical experience